piracetam has been researched along with propranolol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Golikov, AP; Riabinin, VA | 1 |
| Kurako, IuL; Volianskiĭ, VE | 1 |
| Fahs, JJ; Golden, RN; Gualtieri, CT | 1 |
| Dasaeva, LA; Vertel', AE | 1 |
| Aschermann, Z; Horváth, K; Komoly, S; Kovács, A; Kovács, N | 1 |
| Lerner, PP; Lerner, V; Miodownik, C | 1 |
4 review(s) available for piracetam and propranolol
| Article | Year |
|---|---|
[New directions in contemporary pharmacotherapy of parkinsonism (review)].
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Lisuride; Oxprenolol; Parkinson Disease; Piracetam; Piribedil; Propranolol | 1984 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder; Child; Child, Preschool; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Intellectual Disability; Learning Disabilities; Lithium; Mental Disorders; Phobic Disorders; Piracetam; Propranolol; Psychotropic Drugs; Pyridoxine | 1983 |
[Treatment of tardive syndromes].
Topics: Amantadine; Antipsychotic Agents; Botulinum Toxins; Central Nervous System Agents; Cholinergic Antagonists; Clinical Trials as Topic; Clonazepam; Deep Brain Stimulation; Dopamine Antagonists; Ginkgo biloba; Humans; Levetiracetam; Movement Disorders; Nootropic Agents; Piracetam; Primary Prevention; Propranolol; Syndrome; Tetrabenazine; Vitamin E | 2014 |
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; alpha-Tocopherol; Amantadine; Anticonvulsants; Antioxidants; Antipsychotic Agents; Clonazepam; Dopamine Agents; Drugs, Chinese Herbal; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Isoleucine; Isoxazoles; Leucine; Levetiracetam; Melatonin; Movement Disorders; Nootropic Agents; Piracetam; Plant Extracts; Propranolol; Pyridoxine; Resveratrol; Stilbenes; Tetrabenazine; Valine; Vitamins; Zonisamide | 2015 |
3 trial(s) available for piracetam and propranolol
| Article | Year |
|---|---|
[The effect of various types of stress-limiting therapy on the outcome of myocardial infarction].
Topics: Aged; Antioxidants; Clinical Trials as Topic; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Female; Humans; Male; Myocardial Infarction; Phosphocreatine; Piracetam; Propranolol; Sodium Oxybate; Stress, Physiological; Verapamil | 1990 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder; Child; Child, Preschool; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Intellectual Disability; Learning Disabilities; Lithium; Mental Disorders; Phobic Disorders; Piracetam; Propranolol; Psychotropic Drugs; Pyridoxine | 1983 |
[The treatment with antihypertensive and nootropic preparations of hypertension patients working under neuroemotional stress].
Topics: Adult; Antihypertensive Agents; Attention; Drug Therapy, Combination; Humans; Hypertension; Male; Memory; Middle Aged; Nootropic Agents; Occupational Diseases; Physical Fitness; Piracetam; Propranolol; Reserpine; Stress, Psychological | 1996 |
2 other study(ies) available for piracetam and propranolol
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |